Trial Profile
Effect of long term treatment with Sebelipase Alfa Therapy on changes in liver histopathology in children and adults with Lyso-somal Acid Lipase Deficiency
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Sebelipase alfa (Primary)
- Indications Lysosomal storage diseases
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2017 New trial record
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases